LLY

Eli Lilly and Company · NYSE:LLY

1,417.54 USD43.84 +3.19%

Eli Lilly and Company (NYSE:LLY) last traded at 1,417.54 USD, up 3.19% on the day. Over the past year the stock is up 69.26%. Its 52-week range is 850.51 to 1,449.68. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open1,428.83

Day range1,408.36 – 1,449.68

52-week range850.51 – 1,449.68

Volume5.25 M

Average volume (10 days)2.74 M

Market cap1.33 T

P/E46.57

EPS (TTM)30.44

Dividend yield0.47%

Beta (1 year)−0.0688

Revenue (TTM)86.46 B

Employees50.00 K

Performance

+8.69%1 week

+19.47%1 month

+23.42%3 months

+49.38%6 months

+31.69%Year to date

+69.26%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

1,457.92 USD

The average 1-year price target, +2.85% from the last price. See the forecast

Latest headlines

Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
What Eli Lilly and Company (LLY) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.